Rasagiline formulations and processes for their preparation
The subject invention provides a pharmaceutical composition comprising N-propargyl-1(R)-aminoindan mesylate; a pharmaceutically acceptable carrier; and greater than 0.7 ppm but less than 30 ppm in total of a compound having the structure: and any salts of
-
Page/Page column 12-13
(2009/08/16)
More Articles about upstream products of 1175018-74-2